O-GlcNAcylation and cancer / / Ikram El Yazidi-Belkoura, Tony Lefebvre, (editors).
his book gathers reviews and articles on the role of O-GlcNAcylation in cancer underlying the pharmacological targeting of the O-GlcNAcylation enzymes OGT and OGA as a promising anticancer strategy. Particular attention is paid to the involvement of O-GlcNAcylation in the regulation of transcription...
Saved in:
TeilnehmendeR: | |
---|---|
Place / Publishing House: | Basel : : MDPI - Multidisciplinary Digital Publishing Institute,, [2022] ©2022 |
Year of Publication: | 2022 |
Language: | English |
Physical Description: | 1 online resource (112 pages) |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
LEADER | 02278nam a2200313 i 4500 | ||
---|---|---|---|
001 | 993603211604498 | ||
005 | 20230624091530.0 | ||
006 | m o d | ||
007 | cr ||||||||||| | ||
008 | 230624s2022 sz o 000 0 eng d | ||
035 | |a (CKB)5400000000043089 | ||
035 | |a (NjHacI)995400000000043089 | ||
035 | |a (EXLCZ)995400000000043089 | ||
040 | |a NjHacI |b eng |e rda |c NjHacl | ||
050 | 4 | |a QP552.G59 |b .O45 2022 | |
082 | 0 | 4 | |a 572.68 |2 23 |
245 | 0 | 0 | |a O-GlcNAcylation and cancer / |c Ikram El Yazidi-Belkoura, Tony Lefebvre, (editors). |
264 | 1 | |a Basel : |b MDPI - Multidisciplinary Digital Publishing Institute, |c [2022] | |
264 | 4 | |c ©2022 | |
300 | |a 1 online resource (112 pages) | ||
336 | |a text |b txt |2 rdacontent | ||
337 | |a computer |b c |2 rdamedia | ||
338 | |a online resource |b cr |2 rdacarrier | ||
588 | |a Description based on print version record. | ||
520 | |a his book gathers reviews and articles on the role of O-GlcNAcylation in cancer underlying the pharmacological targeting of the O-GlcNAcylation enzymes OGT and OGA as a promising anticancer strategy. Particular attention is paid to the involvement of O-GlcNAcylation in the regulation of transcription and as a link between nutrition and epigenetic dynamics or cellular energy metabolism. The role of O-GlcNAcylation in metastasis, immune responses, and resistance to chemotherapeutic agents is also discussed. | ||
505 | 0 | |a 1. Introduction -- 2. O-GlcNAcylation -- 2.2. Functions of O-GlcNAcylation -- 3. O-GlcNAcylation and Cancer -- 3.1. O-GlcNAcylation and Metastasis -- 3.2. O-GlcNAcylation and Receptor Tyrosine Kinase -- 3.3. O-GlcNAcylation and Resistance to Chemotherapy -- 3.4. O-GlcNAcylation as Prognostic Marker -- 4. O-GlcNAcylation and Immune Responses in Cancer -- 4.1. Overview of Immune System and O-GlcNAcylation -- 4.2. T Cell Activation and Differentiation Regulated by O-GlcNAcylation -- 4.3. Macrophage Differentiation and Activation by O-GlcNAcylation -- 4.4. O-GlcNAcylation and Tumor Microenvironment -- 5. Cancer Therapeutics Targeting O-GlcNAcylation -- 6. Conclusions and Future Perspectives -- Author Contributions -- Funding -- Conflicts of Interest -- Footnotes -- References. | |
650 | 0 | |a Glycosylation. | |
776 | |z 3-0365-3083-5 | ||
700 | 1 | |a Lefebvre, Tony , |e editor. | |
700 | 1 | |a El Yazidi-Belkoura, Ikram, |e editor. | |
906 | |a BOOK | ||
ADM | |b 2023-07-06 03:06:55 Europe/Vienna |f system |c marc21 |a 2022-04-04 09:22:53 Europe/Vienna |g false | ||
AVE | |i DOAB Directory of Open Access Books |P DOAB Directory of Open Access Books |x https://eu02.alma.exlibrisgroup.com/view/uresolver/43ACC_OEAW/openurl?u.ignore_date_coverage=true&portfolio_pid=5337923530004498&Force_direct=true |Z 5337923530004498 |b Available |8 5337923530004498 |